An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care Philippines
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care Philippines
This study is an adaptive, randomized, open-label, controlled clinical trial utilizing an adaptive design to compare effects of repurposed drugs with local standard of care alone on major inpatient hospital outcomes. This is performed worldwide in collaboration with WHO.
Inclusion Criteria:
Consenting adults (age ≥18) hospitalised with the following criteria will be included in the study:
Exclusion Criteria:
Muntinlupa, National Capital Region, Philippines
Muntinlupa, National Capital Region, Philippines
Quezon City, National Capital Region, Philippines